Active14759446Private limited companyLondon

BM TRINITAS PHARMA LIMITED

D39/100

Summary

Generated from filed data · no estimates

BM TRINITAS PHARMA LIMITED is an active private limited company (company number 14759446) incorporated on 27 March 2023, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest dormant accounts cover the period ending 31 March 2026, showing net assets of £0, with 0 employees on average.

Peer position · net assets

By net assets it sits in the lower half of 603 comparable companies in London (median £440, upper quartile £92k).

Key dates

Incorporated: 27 March 20233 yrs ago
Next accounts due: 31 December 2027in 435 days
Confirmation statement due: 10 April 2027in 170 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
SIC 72190: Other research and experimental development on natural sciences and engineering
Accounts type: Dormant
Size band: MicroCompanies Act thresholds

Financials

2 periods on record · latest ending 31 March 2026

Net assets

£0

vs Mar 2025

Cash at bank

Not reported

Turnover

Not reported

Employees

Not reported the period before

Filed accounts by period, newest first
Period end	Net assets	Cash	Debtors	Creditors <1y	Turnover	Profit	Employees
31 March 2026	£0	—	—	£0	—	—	0
31 March 2025	£0	—	—	£0	—	—	—

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

Firmoscan score

Rules-based · every point shows its evidence

39 / 100 · grade D

Score breakdown
50	Starting scoreEvery scored company starts here
−15	Negative net assetsNet assets £0 at 2026-03-31
+4	Past first filingsIncorporated 2023-03-27
39	Score, grade D

A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.

Ownership and control

3 active

SR
Mr Stephen Raymond Self
Individual · since 27 March 2023
- has significant influence or control
PJ
Mr Paul Jonathan Ballington
Individual · since 27 March 2023
- has significant influence or control
BM
Mr Brett Mooney
Individual · since 27 March 2023
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
75–100%

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.

Timeline

Newest first

31 Dec 2027Next accounts duein 435 days
10 Apr 2027Confirmation statement duein 170 days
31 Mar 2026Accounts period endNet assets £0 · dormant accounts
31 Mar 2025Accounts period endNet assets £0 · dormant accounts
27 Mar 2023Incorporated

Similar companies in London

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 27 March 2023 · in Mar 2023.

Reminders for BM TRINITAS PHARMA LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.